AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2020
Mar 20, 2020
29755_dirs_2020-03-20_0c4a9f00-bad6-4bc3-afa9-377787aa1b0a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2020-03-18
Reporting Person: Durkin Brian L (VP, Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-03-18 | Common Stock, $0.01 par value | P | 2200 | $68.184 | Acquired | 15294 | Direct |
| 2020-03-20 | Common Stock, $0.01 par value | P | 800 | $67.50 | Acquired | 16094 | Direct |
| 2020-03-30 | Common Stock, $0.01 par value | P | 750 | $69.00 | Acquired | 16844 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.01 par value | 253 | Indirect |
Footnotes
F1: The reporting person disclaims beneficial ownership of all securities held by his spouse.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4